Cosmetics & Quasi-drugs

Shipments of cosmetics in Japan were worth a total of 1,507 billion yen in 2015. In the same year, Japan imported cosmetics valued at about 244 billion yen, of which some 82 billion yen related to cosmetics from the EU. European cosmetic and quasi-drug products account for such a large share of imports but continue to face substantial market access barriers, such as an overly restrictive regulatory environment, an overly complex product approval system and complicated manufacturing requirements. The committee aims for alignment of Japanese regulations with the rules of the EU which would substantially improve market access and unlock significant potential in the market. View Issues and Recommendations – (English | Japanese) Chairman: Dr. Nobuyuki Hagiwara Head of Regulatory Affairs, Johnson & Johnson K.K. 3-5-2 Nishi-Kanda Chiyoda-ku, Tokyo 101-0065 Tel: +81-3-4411-6118 | Fax: +81-3-4411-7149 Members: Bluebell Japan Ltd. Chanel K.K. Clarins K.K. ELGC K.K. Johnson & Johnson K.K. LVMH Cosmetics K.K. Nihon L'Oreal K.K. Upcoming Committee Meeting Schedule: Please contact the EBC ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it ) to confirm the meeting location prior to attending 2017 September 25th (Mon) 12:30~ EBC

 

Copyright 2017 EBC     Powered by JP-Domains.com